Germline Profiling and Molecular Characterization of Early Onset Metastatic Colorectal CancerTing Xu, Xicheng Wang, Jian Li et al.|Frontiers in Oncology|2020Cited by 47
Abstract CT127: A phase I study of cMET inhibitor bozitinib in patients with advanced NSCLC harboring <i>cMET</i> alterationsJin‐Ji Yang, Yi‐Long Wu, Qing Zhou et al.|Cancer Research|2020Cited by 18
Genomic profiles of BRAF inhibitor resistance mechanisms in metastatic colorectal cancer.Ting Xu, Xi Li, Xicheng Wang et al.|Journal of Clinical Oncology|2021Cited by 5
Additional file 4: of Oncoprotein HBXIP enhances HOXB13 acetylation and co-activates HOXB13 to confer tamoxifen resistance in breast cancerBowen Liu, Lihong Ye, Tianjiao Wang et al.|Figshare|2018Cited by 0